Volunteer Dies During AstraZeneca Vaccine Trial



[ad_1]

Aware: 2020-10-21 20:42

FILE PHOTO: A labeled vaccine is seen on a test tube in front of the AstraZeneca logo in this illustration taken on September 9, 2020. REUTERS / Dado Ruvic / Illustration / File Photo / File Photo

A COVID-19 vaccine developed by AstraZeneca and the University of Oxford died in a volunteer.

This was announced by Reuters, citing the Brazilian health agency ANVISA.

The circumstances of the experience are not recounted in detail. The Federal University of São Paulo, which coordinates three clinical trials in Brazil, reported that the volunteer was Brazilian.

According to the authority, the proof of the vaccine will be tsiamitol.

The vaccine, developed by AstraZeneca and the University of Oxford, is considered one of the most advanced vaccines in the world. Its crews are currently carrying out the final three-stage tests.

AstraZeneca had suspended testing for a volunteer in the UK for several days in mid-September.

At the end of August, the European Commission and AstraZeneca reached an agreement on the purchase of the future vaccine. It stipulates that all Member States will be able to buy 300 million. AstraZeneca vaccine dose. It is also possible to buy an additional 100 million. dose. Vaccines will be distributed in proportion to the population. The Minister of Health, Aurelijus Veryga, announced that it was planned to supply Lithuania with just over 1.8 million. dose of vaccine.

Receive free trade news in your email:

Rayti komentar



[ad_2]